Structured evidence table for Curcumin Skin Health Meta-Analysis, generated from 1 reusable source document in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Curcumin Skin Health Meta-Analysis | In order to tackle the associated challenges, recent developments in pharmaceutical nanotechnology have produced delivery systems based on nanocarriers, including nanostructured lipid carriers (NLCs), solid lipid nanoparticles (SLNs), nanoemulsions, & nanovesicles. | 3 | Sharma Tanuj (2026) | Curcumin-loaded nanocarriers for dermatological applications: current advances and biomedical implications |
| Curcumin Skin Health Meta-Analysis | Between September 2023 and January 2024, 25 active trials (11 Phase II, 14 Phase III) for atopic dermatitis were found (Patel et al., 2024[]). | 3 | Sharma Tanuj (2026) | Curcumin-loaded nanocarriers for dermatological applications: current advances and biomedical implications |
| Curcumin Skin Health Meta-Analysis | 69 69 70 134 118 One important molecule among herbal actives that has demonstrated therapeutic advantages for psoriasis, eczema, acne, hyperpigmentation, skin cancer, and wound healing is curcumin, which is found in turmeric. | 3 | Sharma Tanuj (2026) | Curcumin-loaded nanocarriers for dermatological applications: current advances and biomedical implications |
| Curcumin Skin Health Meta-Analysis | 91 140 40 90 123 84 The skin, recognized as the body's largest organ provides multilayered protection through chemical, immunological, microbiological, and physical barriers, all of which are essential for preserving homeostasis (Norlén, 2023[]). | 3 | Sharma Tanuj (2026) | Curcumin-loaded nanocarriers for dermatological applications: current advances and biomedical implications |
Source documents